Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Research

Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma

Authors: Xulei Huo, Ke Wang, Bohan Yao, Lairong Song, Zirun Li, Wenyan He, Yiming Li, Junpeng Ma, Liang Wang, Zhen Wu

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

The function and regulation of miRNAs in progression of chordoma were unclear.

Methods

Five miRNAs were identified by the machine learning method from the miRNA expression array. CCk-8 assay, EDU assay, wound healing migration assay, and trans-well assay were used to reveal the effect of the miRNAs in chordoma cell lines. Moreover, bioinformation analysis and the mRNA expression array between the primary chordomas and recurrent chordomas were used to find the target protein genes of miRNAs. Furthermore, qRT-PCR and luciferase reporter assay were used to verify the result.

Results

miR-186-5p, miR-30c-5p, miR-151b, and miR-125b-5p could inhibit proliferation, migration, and invasion of chordoma while miR-1260a enhances proliferation, migration, and invasion of chordoma. Recurrent chordoma has a worse disease-free outcome than the primary chordoma patients. AMOT, NPTX1, RYR3, and P2RX5 were the target protein mRNAs of miR-186-5p; NPTX1 was the target protein mRNAs of miR-125b-5p; and AMOT and TNFSF14 were the target protein mRNAs of miR-1260a.

Conclusions

miR-186-5p, miR-125b-5p, miR-1260a, and their target protein mRNAs including AMOT, NPTX1, RYR3, P2RX5, TNFSF14 may be the basement of chordoma research.
Appendix
Available only for authorised users
Literature
1.
go back to reference Salisbury JR, et al. Three-dimensional reconstruction of human embryonic notochords: clue to the pathogenesis of chordoma. J Pathol. 1993;171(1):59–62.CrossRefPubMed Salisbury JR, et al. Three-dimensional reconstruction of human embryonic notochords: clue to the pathogenesis of chordoma. J Pathol. 1993;171(1):59–62.CrossRefPubMed
2.
go back to reference Boriani S, et al. Chordoma of the mobile spine: fifty years of experience. Spine (Phila Pa 1976). 2006;31(4):493–503.CrossRefPubMed Boriani S, et al. Chordoma of the mobile spine: fifty years of experience. Spine (Phila Pa 1976). 2006;31(4):493–503.CrossRefPubMed
3.
go back to reference Jones PS, et al. Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and end results (SEER) database. J Clin Neurosci. 2014;21(9):1490–6.CrossRefPubMed Jones PS, et al. Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and end results (SEER) database. J Clin Neurosci. 2014;21(9):1490–6.CrossRefPubMed
4.
go back to reference Walcott BP, et al. Chordoma: current concepts, management, and future directions. Lancet Oncol. 2012;13(2):e69–76.CrossRefPubMed Walcott BP, et al. Chordoma: current concepts, management, and future directions. Lancet Oncol. 2012;13(2):e69–76.CrossRefPubMed
5.
go back to reference Ludwig N, et al. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs. Neuro Oncol. 2015;17(9):1250–60.CrossRefPubMedPubMedCentral Ludwig N, et al. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs. Neuro Oncol. 2015;17(9):1250–60.CrossRefPubMedPubMedCentral
9.
go back to reference Duan Z, et al. Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression. J Orthop Res. 2010;28(6):746–52.CrossRefPubMed Duan Z, et al. Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression. J Orthop Res. 2010;28(6):746–52.CrossRefPubMed
11.
go back to reference Ma X et al. Long non-coding RNA LOC554202 modulates chordoma cell proliferation and invasion by recruiting EZH2 and regulating miR-31 expression. Cell Prolif, 2017. 50(6). Ma X et al. Long non-coding RNA LOC554202 modulates chordoma cell proliferation and invasion by recruiting EZH2 and regulating miR-31 expression. Cell Prolif, 2017. 50(6).
12.
13.
go back to reference Ma J, et al. Identification of the different roles and potential mechanisms of T isoforms in the Tumor recurrence and cell cycle of Chordomas. Onco Targets Ther. 2019;12:11777–91.CrossRefPubMedPubMedCentral Ma J, et al. Identification of the different roles and potential mechanisms of T isoforms in the Tumor recurrence and cell cycle of Chordomas. Onco Targets Ther. 2019;12:11777–91.CrossRefPubMedPubMedCentral
14.
go back to reference Song LR, et al. MicroRNA-195 functions as a Tumor suppressor by directly targeting fatty acid synthase in malignant meningioma. World Neurosurg. 2020;136:e355–64.CrossRefPubMed Song LR, et al. MicroRNA-195 functions as a Tumor suppressor by directly targeting fatty acid synthase in malignant meningioma. World Neurosurg. 2020;136:e355–64.CrossRefPubMed
15.
go back to reference Ru Y, et al. The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res. 2014;42(17):e133.CrossRefPubMedPubMedCentral Ru Y, et al. The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res. 2014;42(17):e133.CrossRefPubMedPubMedCentral
17.
go back to reference Langdon WB. Performance of genetic programming optimised Bowtie2 on genome comparison and analytic testing (GCAT) benchmarks. BioData Min. 2015;8(1):1.CrossRefPubMedPubMedCentral Langdon WB. Performance of genetic programming optimised Bowtie2 on genome comparison and analytic testing (GCAT) benchmarks. BioData Min. 2015;8(1):1.CrossRefPubMedPubMedCentral
19.
go back to reference Wang Y et al. MiRNA-186-5p Exerts an Anticancer Role in Breast Cancer by Downregulating CXCL13. J Healthc Eng, 2022. 2022: p. 4891889. Wang Y et al. MiRNA-186-5p Exerts an Anticancer Role in Breast Cancer by Downregulating CXCL13. J Healthc Eng, 2022. 2022: p. 4891889.
20.
go back to reference Liu F, Liang Y, Lin X. MiR-151b inhibits osteoblast differentiation via downregulating Msx2. Connect Tissue Res. 2022;63(2):112–23.CrossRefPubMed Liu F, Liang Y, Lin X. MiR-151b inhibits osteoblast differentiation via downregulating Msx2. Connect Tissue Res. 2022;63(2):112–23.CrossRefPubMed
21.
go back to reference Tang L, et al. MicroRNA-125b-5p correlates with prognosis and lung adenocarcinoma progression. Front Mol Biosci. 2021;8:788690.CrossRefPubMed Tang L, et al. MicroRNA-125b-5p correlates with prognosis and lung adenocarcinoma progression. Front Mol Biosci. 2021;8:788690.CrossRefPubMed
22.
go back to reference de Los Santos-Jimenez J, et al. Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells. J Biomed Sci. 2021;28(1):14.CrossRef de Los Santos-Jimenez J, et al. Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells. J Biomed Sci. 2021;28(1):14.CrossRef
23.
go back to reference Deng Y, Wu J, Li X. lncRNA RUNDC3A-AS1 regulates proliferation and apoptosis of thyroid Cancer cells via the miR-151b/SNRPB Axis. Int J Endocrinol. 2022;2022:9433434.CrossRefPubMedPubMedCentral Deng Y, Wu J, Li X. lncRNA RUNDC3A-AS1 regulates proliferation and apoptosis of thyroid Cancer cells via the miR-151b/SNRPB Axis. Int J Endocrinol. 2022;2022:9433434.CrossRefPubMedPubMedCentral
25.
go back to reference Ruan WD, et al. MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells. Onco Targets Ther. 2016;9:303–13.CrossRefPubMedPubMedCentral Ruan WD, et al. MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells. Onco Targets Ther. 2016;9:303–13.CrossRefPubMedPubMedCentral
26.
go back to reference Ruan W, et al. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells. Tumour Biol. 2016;37(3):4065–73.CrossRefPubMed Ruan W, et al. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells. Tumour Biol. 2016;37(3):4065–73.CrossRefPubMed
27.
go back to reference Peng X, et al. NPTX1 inhibits colon cancer cell proliferation through down-regulating cyclin A2 and CDK2 expression. Cell Biol Int. 2018;42(5):589–97.CrossRefPubMed Peng X, et al. NPTX1 inhibits colon cancer cell proliferation through down-regulating cyclin A2 and CDK2 expression. Cell Biol Int. 2018;42(5):589–97.CrossRefPubMed
29.
go back to reference Brunetti G, et al. LIGHT/TNFSF14 promotes osteolytic bone metastases in non-small cell Lung Cancer Patients. J Bone Miner Res. 2020;35(4):671–80.CrossRefPubMed Brunetti G, et al. LIGHT/TNFSF14 promotes osteolytic bone metastases in non-small cell Lung Cancer Patients. J Bone Miner Res. 2020;35(4):671–80.CrossRefPubMed
30.
go back to reference Zhang L, et al. Functional SNP in the microRNA-367 binding site in the 3’UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification. Proc Natl Acad Sci U S A. 2011;108(33):13653–8.CrossRefPubMedPubMedCentral Zhang L, et al. Functional SNP in the microRNA-367 binding site in the 3’UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification. Proc Natl Acad Sci U S A. 2011;108(33):13653–8.CrossRefPubMedPubMedCentral
31.
go back to reference Sarquis M, et al. Germline mutations in familial papillary thyroid Cancer. Endocr Pathol. 2020;31(1):14–20.CrossRefPubMed Sarquis M, et al. Germline mutations in familial papillary thyroid Cancer. Endocr Pathol. 2020;31(1):14–20.CrossRefPubMed
Metadata
Title
Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma
Authors
Xulei Huo
Ke Wang
Bohan Yao
Lairong Song
Zirun Li
Wenyan He
Yiming Li
Junpeng Ma
Liang Wang
Zhen Wu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11238-x

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine